Form 4: Niagen Bioscience Insider Buys Shares

Niagen Bioscience, Inc. (NAGE) Chief Financial Officer Pamir Ozan acquired shares through the company's Employee Stock Purchase Plan.

Summary

• Pamir Ozan, Chief Financial Officer of Niagen Bioscience, Inc. (NAGE), acquired 4,255 shares of common stock on June 30, 2026.
• The acquisition was made through the Issuer's Employee Stock Purchase Plan.
• The purchase price was $2.71 per share, totaling $11,627.15.
• Following this transaction, Ozan beneficially owns 11,627.159 shares directly.
• An additional 2,220.443 shares are held indirectly by Ozan's spouse.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents an insider acquiring shares, which can indicate confidence, but it is a routine transaction through an employee plan.

Positives

• Insider purchase of company stock by a key executive (CFO).
• Acquisition made through an Employee Stock Purchase Plan, indicating employee participation and potential confidence in the company.
• The transaction is exempt under Rule 16b-3(c) and 16b-3(d).

Future Outlook

No specific future outlook or guidance is provided in this filing, which is a statement of changes in beneficial ownership.

Industry Context

StockSavvy.ai notes that insider purchases, especially by CFOs, can signal confidence in the company's financial health and future prospects. This type of transaction is common in the biotechnology sector as companies navigate development and commercialization phases.

Stakeholder Impact

• Shareholders may view this as a positive signal of executive confidence in the company's stock.
• Employees participating in the Employee Stock Purchase Plan are demonstrating commitment to the company.

Key Dates

Keywords

Niagen Bioscience, NAGE, Form 4, Insider Trading, Employee Stock Purchase Plan, Pamir Ozan, Chief Financial Officer, Common Stock, Beneficial Ownership